329 related articles for article (PubMed ID: 19522425)
41. [Correlation between bronchoalveolar lavage fluid angiotensin converting enzyme levels and T cell subsets in patients with sarcoidosis].
Li ZH; Li YL; Hou XM
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Aug; 17(4):235-7, 255-6. PubMed ID: 7834789
[TBL] [Abstract][Full Text] [Related]
42. Bronchoalveolar lavage cytology in pulmonary sarcoidosis.
Zaman SS; Elshami A; Gupta PK
Acta Cytol; 1995; 39(6):1117-23. PubMed ID: 7483985
[TBL] [Abstract][Full Text] [Related]
43. Simple flow cytometric protocol of CD4+/CD8+ lymphocyte ratio assessment in bronchoalveolar lavage fluids from patients with interstitial lung diseases.
Szpechcinski A; Kopinski P; Giedronowicz D; Rozy A; Jagus P; Szolkowska M; Chorostowska-Wynimko J
Anal Quant Cytol Histol; 2011 Oct; 33(5):289-96. PubMed ID: 22611757
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis.
Danila E; Norkūniene J; Jurgauskiene L; Malickaite R
Clin Respir J; 2009 Oct; 3(4):214-21. PubMed ID: 20298407
[TBL] [Abstract][Full Text] [Related]
45. The prognostic value of bronchoalveolar lavage in sarcoidosis.
Tukiainen P; Taskinen E; Riska H
Sarcoidosis; 1994 Mar; 11(1):69-72. PubMed ID: 8036349
[No Abstract] [Full Text] [Related]
46. [Cyclooxygenase-2 polymorphisms and bronchoalveolar lavage cellularity of sarcoidosis].
López-Campos JL; Rodríguez-Rodríguez D; Rodríguez-Becerra E; Alfageme-Michavila I; Fernández-Guerra J; García-Hernández FJ; Casanova A; Fernández de Córdoba J; Romero-Ortiz A; Arellano-Orden E; Montes-Worboys A
Rev Invest Clin; 2010; 62(5):440-6. PubMed ID: 21416732
[TBL] [Abstract][Full Text] [Related]
47. Bronchoalveolar lavage in a patient with recurrence of sarcoidosis after lung transplantation.
Slebos DJ; Verschuuren EA; Koëter GH; van der Bij W; Kauffman HF; Postma DS; Timens W
J Heart Lung Transplant; 2004 Aug; 23(8):1010-3. PubMed ID: 15312833
[TBL] [Abstract][Full Text] [Related]
48. [Analysis of cells and proteins in bronchoalveolar lavage fluid].
Hanaoka M; Fujimoto K; Hayasaka M; Kubo K; Kobayashi T; Sekiguchi M; Honda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):259-65. PubMed ID: 8778463
[TBL] [Abstract][Full Text] [Related]
49. Clinical evaluation of lymphocyte sub-populations and oxygen radical production in sarcoidosis and idiopathic pulmonary fibrosis.
Groen H; Hamstra M; Aalbers R; van der Mark TW; Koëter GH; Postma DS
Respir Med; 1994 Jan; 88(1):55-64. PubMed ID: 8029515
[TBL] [Abstract][Full Text] [Related]
50. Value of s-ACE, BAL lymphocytosis, and CD4+/CD8+ and CD103+CD4+/CD4+ T-cell ratios in diagnosis of sarcoidosis.
Hyldgaard C; Kaae S; Riddervold M; Hoffmann HJ; Hilberg O
Eur Respir J; 2012 Apr; 39(4):1037-9. PubMed ID: 22467726
[No Abstract] [Full Text] [Related]
51. Correlation of CD4:CD8 ratio and tumour necrosis factor (TNF)alpha levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis.
Moodley YP; Dorasamy T; Venketasamy S; Naicker V; Lalloo UG
Thorax; 2000 Aug; 55(8):696-9. PubMed ID: 10899249
[TBL] [Abstract][Full Text] [Related]
52. [Cytological study of deep lung in spondyloarthritis. Apropos of 34 cases].
Bonnet D; Jeandel P; Chouc PY; Molinier S; Raphenon G; Martet G; Merouze F; de Muizon H
Rev Pneumol Clin; 1993; 49(2):100-5. PubMed ID: 8272738
[TBL] [Abstract][Full Text] [Related]
53. Neurotrophin system activation in bronchoalveolar lavage fluid immune cells in pulmonary sarcoidosis.
Ricci A; Mariotta S; Saltini C; Falasca C; Giovagnoli MR; Mannino F; Graziano P; Sciacchitano S; Amenta F
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):186-94. PubMed ID: 16315781
[TBL] [Abstract][Full Text] [Related]
54. Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis.
Fuhrman C; Parrot A; Wislez M; Prigent H; Boussaud V; Bernaudin JF; Mayaud C; Cadranel J
Am J Respir Crit Care Med; 2001 Oct; 164(7):1186-91. PubMed ID: 11673207
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of neutrophils and NK cells in bronchoalveolar lavage of sarcoidosis.
Tutor-Ureta P; Citores MJ; Castejón R; Mellor-Pita S; Yebra-Bango M; Romero Y; Vargas JA
Cytometry B Clin Cytom; 2006 Nov; 70(6):416-22. PubMed ID: 16977633
[TBL] [Abstract][Full Text] [Related]
56. [Comparison of cellular composition of induced sputum, bronchial washings and bronchoalveolar lavage fluid in sarcoidosis, hypersensitivity pneumonitis and COPD].
Mróz RM; Chyczewska E; Korniluk M; Stasiak-Barmuta A; Ossolińska M
Pneumonol Alergol Pol; 2002; 70(9-10):468-77. PubMed ID: 12710099
[TBL] [Abstract][Full Text] [Related]
57. [Diagnosis and parameters for the evaluation of disease activity and prognosis in patients with pulmonary sarcoidosis].
Nagai S
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):86-91. PubMed ID: 2162436
[TBL] [Abstract][Full Text] [Related]
58. Bal T lymphocyte subsets are reduced in primary lung neoplasias.
Cascio G; Anania A; Mazzetti R; Scappaticci E; Canavera RM; Marinuzzi G
Panminerva Med; 1993 Sep; 35(3):127-30. PubMed ID: 8090525
[TBL] [Abstract][Full Text] [Related]
59. [The role of BAL in the process of decision making with regard to the treatment of sarcoidosis].
Załeska J; Pirozyński M; Sokolnicka I; Derentowicz P; Radwan L; Roszkowski W; Rowińska-Zakrzewska E
Pneumonol Pol; 1990; 58(4-5):167-72. PubMed ID: 2392380
[TBL] [Abstract][Full Text] [Related]
60. [Sarcoidosis and tobacco smoking--clinical picture, diagnostic tests results and bronchoalveolar lavage fluid composition].
Urbankowski T; Knyziak-Medrzycka I; Domagała-Kulawik J; Chazan R
Pol Merkur Lekarski; 2012 May; 32(191):298-301. PubMed ID: 22779335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
